Eleva, a pioneer in unlocking biologics based on a breakthrough manufacturing platform, and 3PBIOVIAN, a contract development and manufacturing organization (CDMO), have partnered to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva’s technology platform. Under the terms of the agreement, Eleva secures production capacity at 3PBIOVIAN for the clinical-grade material needed to advance its current pipeline programs into mid- to late-stage...